Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher T Saeui

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Functional Biomaterials|June 23, 2015
Cell Surface and Membrane Engineering: Emerging Technologies and ApplicationsChristopher T Saeui, Mohit P Mathew, Lingshui Liu, et al.
Glycoconjugate Journal|May 2, 2015
Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applicationsChristopher T Saeui, Esteban Urias, Lingshu Liu, et al.
Frontiers in Immunology|November 20, 2018
Improving Immunotherapy Through GlycodesignMatthew J Buettner, Sagar R Shah, Christopher T Saeui, et al.
Cells|March 6, 2021
Glycoengineering Human Neural and Adipose Stem Cells with Novel Thiol-Modified <i>N</i>-Acetylmannosamine (ManNAc) AnalogsJian Du, Christian Agatemor, Christopher T Saeui, et al.
Molecular Pharmaceutics|August 31, 2017
Pharmacological, Physiochemical, and Drug-Relevant Biological Properties of Short Chain Fatty Acid Hexosamine Analogues Used in Metabolic GlycoengineeringChristopher T Saeui, Lingshu Liu, Esteban Urias, et al.
Nature Reviews. Chemistry|November 29, 2019
Exploiting metabolic glycoengineering to advance healthcareChristian Agatemor, Matthew J Buettner, Ryan Ariss, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2015
Metabolic glycoengineering sensitizes drug-resistant pancreatic cancer cells to tyrosine kinase inhibitors erlotinib and gefitinibMohit P Mathew, Elaine Tan, Christopher T Saeui, et al.
Oncotarget|September 11, 2016
Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cellsMohit P Mathew, Elaine Tan, Christopher T Saeui, et al.
Biomaterials|December 8, 2016
Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering exampleHaitham A Badr, Dina M M AlSadek, Motawa E El-Houseini, et al.
Chembiochem : a European Journal of Chemical Biology|February 21, 2017
Glycoengineering of Esterase Activity through Metabolic Flux-Based Modulation of Sialic AcidMohit P Mathew, Elaine Tan, Jason W Labonte, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Functional Biomaterials|June 23, 2015
Cell Surface and Membrane Engineering: Emerging Technologies and ApplicationsChristopher T Saeui, Mohit P Mathew, Lingshui Liu, et al.
Glycoconjugate Journal|May 2, 2015
Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applicationsChristopher T Saeui, Esteban Urias, Lingshu Liu, et al.
Frontiers in Immunology|November 20, 2018
Improving Immunotherapy Through GlycodesignMatthew J Buettner, Sagar R Shah, Christopher T Saeui, et al.
Cells|March 6, 2021
Glycoengineering Human Neural and Adipose Stem Cells with Novel Thiol-Modified <i>N</i>-Acetylmannosamine (ManNAc) AnalogsJian Du, Christian Agatemor, Christopher T Saeui, et al.
Molecular Pharmaceutics|August 31, 2017
Pharmacological, Physiochemical, and Drug-Relevant Biological Properties of Short Chain Fatty Acid Hexosamine Analogues Used in Metabolic GlycoengineeringChristopher T Saeui, Lingshu Liu, Esteban Urias, et al.
Nature Reviews. Chemistry|November 29, 2019
Exploiting metabolic glycoengineering to advance healthcareChristian Agatemor, Matthew J Buettner, Ryan Ariss, et al.
Bioorganic & Medicinal Chemistry Letters|February 19, 2015
Metabolic glycoengineering sensitizes drug-resistant pancreatic cancer cells to tyrosine kinase inhibitors erlotinib and gefitinibMohit P Mathew, Elaine Tan, Christopher T Saeui, et al.
Oncotarget|September 11, 2016
Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cellsMohit P Mathew, Elaine Tan, Christopher T Saeui, et al.
Biomaterials|December 8, 2016
Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering exampleHaitham A Badr, Dina M M AlSadek, Motawa E El-Houseini, et al.
Chembiochem : a European Journal of Chemical Biology|February 21, 2017
Glycoengineering of Esterase Activity through Metabolic Flux-Based Modulation of Sialic AcidMohit P Mathew, Elaine Tan, Jason W Labonte, et al.
Pageof 3